Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas.

Abstract

PURPOSE To evaluate the effect of two filgrastim dosages after autologous bone marrow transplantation (ABMT) in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). PATIENTS AND METHODS Eighty-six patients were enrolled onto a multicenter, randomized, open-label study. The study compared the efficacy and safety of two different doses of… (More)

Topics

Cite this paper

@article{Stahel1997RandomizedTS, title={Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas.}, author={Roif A. Stahel and Lorna Jost and H. P. Honegger and Elizabeth S. Betts and Matthias G{\"o}bel and Arnon Nagler}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={1997}, volume={15 5}, pages={1730-5} }